Biotest AG operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Biotest AG with three other
pharmaceutical manufacturers in Europe:
sales of 607.80 million Euro [US$650.75 million]
of which 51%
was Non-Proprietary Homeopathic Medicines),
(684.99 million Euro [US$733.39 million]
of which 69%
was Own Network (Spain)), and
based in Ireland
(569.69 million Euro [US$609.94 million]
of which 100%
During the year ended December of 2015, sales at
Biotest AG were 589.60 million Euro (US$631.26 million).
a very small
increase of 1.3%
versus 2014, when the company's sales were 582.00 million Euro.
This was the fifth consecutive year of sales increases at Biotest AG
(and since 2010, sales have increased a total of 43%).
Sales of Plasma and Services saw an increase
that was more than double the company's growth rate: sales were up
8.1% in 2015, from
157.00 million Euro to 169.70 million Euro.
Not all segments of Biotest AG experienced an increase in sales in 2015:
sales of Other fell 44.1% to 8.50 million Euro.
(However, this segment's sales were only a very small portion of the company's overall sales).